SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-016559
Filing Date
2017-08-08
Accepted
2017-08-08 16:28:31
Documents
49
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acad-10q_20170630.htm 10-Q 1361670
2 EX-10.1 acad-ex101_64.htm EX-10.1 15119
3 EX-10.3 acad-ex103_94.htm EX-10.3 128963
4 EX-31.1 acad-ex311_7.htm EX-31.1 9503
5 EX-31.2 acad-ex312_66.htm EX-31.2 9233
6 EX-32.1 acad-ex321_6.htm EX-32.1 6366
7 EX-32.2 acad-ex322_65.htm EX-32.2 6399
  Complete submission text file 0001564590-17-016559.txt   3963020

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT acad-20170630.xml EX-101.INS 730218
9 XBRL TAXONOMY EXTENSION SCHEMA acad-20170630.xsd EX-101.SCH 24105
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20170630_cal.xml EX-101.CAL 40281
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20170630_def.xml EX-101.DEF 45072
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20170630_lab.xml EX-101.LAB 192693
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20170630_pre.xml EX-101.PRE 138377
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 171015184
SIC: 2834 Pharmaceutical Preparations